Metformin use tied to lower incidence of death, long COVID after COVID-19
By
HealthDay News
Sep 19, 2024
The incidence of death or postacute sequelae of SARS-CoV-2 was slightly lower with prevalent metformin use.
Personality tied to cardiovascular disease risk with type 2 diabetes
By
HealthDay News
Sep 17, 2024
A lower diligence level was linked to the risk for new cardiovascular disease, but a healthy lifestyle still was beneficial.
Positive airway pressure use tied to lower cardiovascular events
By
HealthDay News
Sep 17, 2024
Over several years, lower all-cause mortality and major adverse cardiovascular events can be seen.
Caffeine, coffee linked to lower cardiometabolic multimorbidity risk
By
HealthDay News
Sep 18, 2024
Habitual caffeine or coffee intake, especially at moderate levels, was linked to a lower risk for new-onset cardiometabolic multimorbidity, which was defined as the coexistence of at least two of type...
FDA expands use of breast cancer drug Kisqali
By
HealthDay News
Sep 18, 2024
The medication already was approved for advanced disease.
Study explores demand for psilocybin-assisted therapy in US
By
HealthDay News
Sep 18, 2024
The estimated percentage eligible ranges from 24 to 62% depending on the eligibility criteria used.
Racial disparities seen in prehospital stroke care
By
HealthDay News
Sep 18, 2024
The findings were seen despite similar use of emergency medical services transport.
Cost has many going around doctors to get weight-loss medications
By
HealthDay News
Sep 18, 2024
Wegovy, Zepbound and other cutting-edge weight-loss drugs are in short supply and often too expensive to afford without insurance coverage.
Predictive models for HTN screening developed using speech recordings
By
HealthDay News
Sep 13, 2024
Accuracies were up to 84 percent for women and 77 percent for men using HTN threshold of SBP ≥135 mmHg and DBP ≥85 mmHg
Once-weekly efsitora noninferior to degludec for type 2 diabetes
By
HealthDay News
Sep 13, 2024
Once-weekly efsitora was noninferior to once-daily degludec for a decrease in the mean glycated hemoglobin level.